3-methoxytyrosine has been researched along with Central Nervous System Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubach, MP | 1 |
| Mukemba, JP | 1 |
| Florence, SM | 1 |
| Lopansri, BK | 1 |
| Hyland, K | 1 |
| Simmons, RA | 1 |
| Langelier, C | 1 |
| Nakielny, S | 1 |
| DeRisi, JL | 1 |
| Yeo, TW | 1 |
| Anstey, NM | 1 |
| Weinberg, JB | 1 |
| Mwaikambo, ED | 1 |
| Granger, DL | 1 |
1 other study available for 3-methoxytyrosine and Central Nervous System Disease
| Article | Year |
|---|---|
Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.
Topics: Biopterins; Central Nervous System Diseases; Child; Child, Preschool; Female; Homovanillic Acid; Hum | 2021 |